Daniel W. Muehl
2018 - Clovis Oncology
Compensation breakdown
Bonus | $156,169 |
---|---|
Option Awards | $388,014 |
Salary | $424,000 |
Stock Awards | $525,870 |
Other | $15,530 |
Total | $1,509,583 |
Muehl received $525.9K in stock awards, accounting for 35% of the total pay in 2018.
Muehl also received $156.2K in bonus, $388K in option awards, $424K in salary and $15.5K in other compensation.
Rankings
In 2018, Daniel W. Muehl's compensation ranked 7,127th out of 14,244 executives tracked by ExecPay. In other words, Muehl earned more than 50.0% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 7,127 | 50th |
Manufacturing | 2,746 | 52nd |
Chemicals And Allied Products | 1,034 | 51st |
Drugs | 873 | 52nd |
Pharmaceutical Preparations | 682 | 51st |
Pay ratio
Daniel W. Muehl's Pay | $1,509,583 |
---|---|
Median Employee's Pay | $349,809 |
Pay Ratio | 4to 1 |
In 2018, the annual total compensation of Daniel W. Muehl was $1,509,583.
The annual total compensation of the median employee at Clovis Oncology was $349,809.
The ratio of Daniel W. Muehl's pay to the pay of median employee was therefore 4 to one.
Muehl's colleagues
We found four more compensation records of executives who worked with Daniel W. Muehl at Clovis Oncology in 2018.
News
April 27, 2022
April 28, 2021
April 24, 2020
April 26, 2019